BNB Microstrategy’s Descent: From Nasdaq to “Nasdaq-ish” 🐸

by

Windtree, a biotech-turned-BNB-treasury firm, is facing delisting from the Nasdaq on August 21. If you’re wondering how a company can pivot from “biotech” to “treasury,” let’s just say it’s like trading your grandma’s knitting for a cryptocurrency-themed bingo card. 🧶➡️🎰

Windtree’s stock price has plummeted 97.74% in six months, now trading at $0.11. For context, that’s about the cost of a single espresso shot-or what you’d pay to hear someone explain NFTs for the 43rd time. ☕

  • Nasdaq is set to delist Windtree on August 21, following non-compliance with its $1 share price rule. Because nothing says “financial stability” like trading at the price of a gum ball.
  • Windtree’s stock price lost 97.74% in the past six months, to $0.11. A 97.74% drop is the financial equivalent of a reality TV show: dramatic, unsustainable, and best watched with a bowl of popcorn.
  • Delisting would make it much harder for Windtree to gain access to public markets. Good luck, though-public markets seem to have moved on to shorting banana stocks.

Struggling biotech Windtree’s pivot to BNB treasuries could soon come to an end. On Tuesday, August 19, regulatory filings showed that Windtree, sometimes called “BNB Microstrategy,” is facing imminent delisting on Nasdaq over non-compliance. If this were a movie, it’d be titled “The Great Token Heist”-but with fewer explosions and more spreadsheets. 🚀

According to the filing with the SEC, Nasdaq will delist Windtree on August 21. Namely, Nasdaq companies must trade above $1 per share, while Windtree, under the ticker WINT, is trading at $0.11. That’s not a stock-it’s a cry for help. 🆘

Critically, the move could place Windtree’s pivot to BNB treasuries at risk. Specifically, the Nasdaq listing effectively turns Windtree into a leveraged play on BNB available on the public market. Without access to the Nasdaq, it would be more difficult for average investors to acquire Windtree’s stock. Which is probably for the best, unless you enjoy financial rollercoasters. 🎢

Struggling Windtree pivoted to BNB treasuries

Windtree, a biotech firm, announced its pivot to a BNB treasury firm after years of slow business. In the past six months, its stock price has fallen 97.74% to its current level of $0.11. If this were a personal finance blog, the headline would read “How I Lost $9.89 in a Day (and Why You Shouldn’t Try This at Home).” 📉

On July 16, the company first announced plans to purchase $60 million worth of BNB tokens from Build and Build Corp., with the potential to acquire $140 million more. This put the company’s total financing up to $200 million for its BNB treasury. For perspective, $200 million is the price of a mid-sized asteroid-or a very expensive coffee table. ☕💸

Just a week later, on July 24, the firm announced securing another $520 million in financing. $500 would come from an equity line of credit agreement with an undisclosed financier, and another $20 million from a direct stock purchase from Build and Build Corp. If you’re keeping track at home, that’s enough money to fund a small country-or a very large TikTok ad campaign. 📱

And there you have it: a financial saga where the real hero is the espresso shot. ☕

Read More

2025-08-20 23:36